David Schade

Endocrinology in Albuquerque, New Mexico

Practice Details

Address
5 Th Ambulatory Care Ctr
Albuquerque, NM 87131
Taxonomy
Endocrinology, Diabetes & Metabolism
NPPES Enumeration
Listed with NPPES since 2006
Sole Proprietor
No
Provider Gender (NPPES)
Male
NPPES Record Updated
October 2024

About This Clinician

This clinician is enumerated under Endocrinology, Diabetes & Metabolism. Endocrinologists treat hormonal and metabolic conditions including type 2 diabetes, and frequently prescribe GLP-1 medications such as semaglutide or tirzepatide as part of diabetes or metabolic-syndrome management — though not every endocrinology practice treats obesity as a primary focus, and some see only referred, complex cases.

Locally, this is 1 of 28 Endocrinology, Diabetes & Metabolism practices in Albuquerque carrying this exact taxonomy in our directory.

What to expect at an Endocrinology visit

Endocrinology visits focus on hormonal and metabolic conditions. For a GLP-1-related consult, patients commonly encounter:

  • A review of diabetes, thyroid, or metabolic history and current medications.
  • Lab work such as A1c and a metabolic panel to guide diagnosis and dosing.
  • A discussion of whether a GLP-1 medication fits the treatment goal (diabetes control, weight, or both).
  • Follow-up scheduling to titrate dose and monitor response over time.

This is general guidance for endocrinology practices, not a description of David Schade's specific protocol, services, or pricing. Confirm what a visit involves directly with the practice — 505-272-3840.

GLP-1 access in Albuquerque, New Mexico

Adult obesity rate
31.7%
#29 of 50 states (CDC BRFSS)
Avg. compounded semaglutide
$199/mo
Typical New Mexico telehealth cash price
Medicaid GLP-1 coverage
Diabetes + obesity (with prior auth)
New Mexico Medicaid, obesity indication

About 31.7% of New Mexico adults have obesity (BMI 30+), ranking the state #29 of 50 (CDC BRFSS). Our directory currently lists 52 GLP-1-relevant clinics in Albuquerque. If a cash-pay route makes more sense, compounded semaglutide through New Mexico telehealth averages about $199/mo — well below brand-name Wegovy or Zepbound.

Explore more New Mexico options on the best New Mexico GLP-1 providers page, browse every Albuquerque listing in the Albuquerque clinic directory.

Related Practices in Albuquerque

Other Albuquerque listings in the same directory tier:

Telehealth Alternative

Prefer not to visit in person? Licensed GLP-1 telehealth providers ship compounded semaglutide or tirzepatide directly to New Mexico addresses, often faster and at lower cash cost than an in-person visit and brand-name prescription. Featured New Mexico telehealth partners:

Featured Partners · Albuquerque

Featured GLP-1 providers serving Albuquerque

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

  1. Top pick

    Compounded from

    $249.99/mo

    Save $1,099.01/mo vs Wegovy
    Get started →
  2. Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  3. Compounded from

    $199/mo

    Save $1,150/mo vs Wegovy
    Get started →
  4. Compounded from

    $147/mo

    Save $1,202/mo vs Wegovy
    Get started →
  5. 8.2

    Compounded from

    $149/mo

    Save $937/mo vs Zepbound
    Get started →
  6. Compounded from

    $249/mo

    Save $1,100/mo vs Wegovy
    Get started →

See more Albuquerque options on the Albuquerque clinic directory, our Albuquerque GLP-1 telehealth page, or compare the best semaglutide providers nationwide.

Learn more about the medications most commonly prescribed by Albuquerque obesity-medicine and endocrinology practices: Semaglutide and Tirzepatide.

Frequently Asked Questions

The CMS National Provider registry lists David Schade's specialty taxonomy but not the specific medications it prescribes or its current service menu. David Schade is listed under Endocrinology, a field where GLP-1 medications such as semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro) are commonly prescribed — but whether this practice currently offers them isn't recorded in the registry. Call the practice at 505-272-3840 to confirm before booking.
According to its CMS National Provider registry (NPPES) record, David Schade's primary specialty on file is Endocrinology.
David Schade is located at 5 Th Ambulatory Care Ctr, Albuquerque, NM 87131. The phone number listed in the registry is 505-272-3840. Its full record is public in the CMS National Provider registry under NPI 1154337756.
New-patient status isn't recorded in the CMS National Provider registry, so we can't confirm whether David Schade is currently accepting new patients. Call the practice at 505-272-3840 to confirm availability, cash-pay pricing, and whether the services you need are offered — this listing reflects the NPPES taxonomy on file and is not an endorsement.